The review of the safety of isotretinoin has concluded.
Similar Posts
Class 4 Medicines Defect Notification: Dulcolax Adult 5 mg Gastro-resistant Tablets, Opella Healthcare UK, EL(25)A/26
Opella Healthcare UK LTD has informed the MHRA that there is an error on the artwork for the outer carton of Dulcolax Adult 5mg GR Tablets (packsize 20 count). The dose instruction incorrectly states for use in 12 years and older. These general sale packs are intended for use only in adult patients (18 years and over).
MHRA MedRegs blog – Summer 2025
Updates on regulatory reform and plans to support innovation.
Field Safety Notices: 15 to 19 September 2025
List of Field Safety Notices from 15 to 19 September 2025.
Professor Alastair Denniston: The future regulation of AI in healthcare
Creating a framework that is safe, fast and trusted.
Variations to marketing authorisations (MAs)
How the MHRA processes variations to marketing authorisations.
Project Orbis
Project Orbis is a programme to review and approve promising cancer drugs helping patients access treatments faster.
